LONG-TERM OUTCOMES OF TESTOSTERONE REPLACEMENT THERAPY FOR PATIENTS WITH LATE-ONSET HYPOGONADISM SYNDROME

被引：0
|
作者：
Ohira, S. [1 ]
Jo, T. [1 ]
Kakumae, S. [1 ]
Nakatsuka, T. [1 ]
Morinaka, H. [1 ]
Takasaki, H. [1 ]
Hirata, K. [1 ]
Sugiyama, S. [1 ]
Shimizu, S. [1 ]
Kaifu, M. [1 ]
Fujii, T. [1 ]
Miyaji, Y. [1 ]
Nagai, A. [1 ]
机构：
[1] Kawasaki Med Sch, Dept Urol, Kurashiki, Okayama, Japan
来源：
JOURNAL OF SEXUAL MEDICINE | 2022年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
128
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [31] Baseline LH Level Predicts the Efficacy of Testosterone Replacement for Late-Onset Hypogonadism
    Shirai, Masato
    Hisasue, Shin-ichi
    Matsushita, Kazuhito
    Shimizu, Fumitaka
    Wakumoto, Yoshiaki
    Horie, Shigeo
    JOURNAL OF MENS HEALTH, 2014, 11 (01) : A5 - A5
  • [32] LUTEINIZING HORMONE LEVEL PREDICTS THE EFFICACY OF TESTOSTERONE REPLACEMENT FOR LATE-ONSET HYPOGONADISM
    Abdelhamed, A.
    Hisasue, S.
    Shirai, M.
    Matsushita, K.
    Kimura, M.
    Ide, H.
    Muto, S.
    Yamaguchi, R.
    Tsujimura, A.
    Horie, S.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 83 - 83
  • [33] PROSPECTIVE ASSESSMENT OF PSYCHOLOGICAL SYMPTOMS IN MEN WITH LATE-ONSET HYPOGONADISM WHO RECEIVED TESTOSTERONE REPLACEMENT THERAPY
    Sumii, Kenta
    Tanaka, Mikito
    Ishida, Takaki
    Enatsu, Noritoshi
    Chiba, Koji
    Matsushita, Kei
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1160 - E1160
  • [34] Vitamin D Status Determines Cardiometabolic Effects of Testosterone Replacement Therapy in Men with Late-Onset Hypogonadism
    Krysiak, Robert
    Kowalcze, Karolina
    Szkrobka, Witold
    Okopien, Boguslaw
    NUTRIENTS, 2025, 17 (06)
  • [35] Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism - A randomized controlled trial
    Marks, Leonard S.
    Mazer, Norman A.
    Mostaghel, Elahe
    Hess, David L.
    Dorey, Frederick J.
    Epstein, Jonathan I.
    Veltri, Robert W.
    Makarov, Danil V.
    Partin, Alan W.
    Bostwick, David G.
    Macairan, Maria Luz
    Nelson, Peter S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (19): : 2351 - 2361
  • [36] Late-onset hypogonadism:Reductio ad absurdumof the cardiovascular risk-benefit of testosterone replacement therapy
    Sesti, Franz
    Pofi, Riccardo
    Minnetti, Marianna
    Tenuta, Marta
    Gianfrilli, Daniele
    Isidori, Andrea M.
    ANDROLOGY, 2020, 8 (06) : 1614 - 1627
  • [37] Testosterone replacement therapy contributes to improving lower urinary tract symptoms in men with late-onset hypogonadism
    Shin, H.
    Kim, D.
    Park, J.
    Jung, H.
    BJU INTERNATIONAL, 2019, 123 : 41 - 41
  • [38] Predictive factors for efficacy of testosterone replacement therapy for late-onset hypogonadism in Japanese men: a preliminary report
    Kondoh, Nobuyuki
    Kaizuka, Yohei
    Nagasawa, Seiji
    Togo, Yoshikazu
    Yamamoto, Shingo
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (05): : 587 - 590
  • [39] Clinical efficiency of combination therapy using testosterone replacement therapy, phosphodiesterase 5 inhibitors and Kampo herbal medicine for eugonadal patients with late-onset hypogonadism syndrome
    Takeuchi, Hisashi
    Okubo, Hidenori
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
  • [40] CLINICAL EFFICIENCY OF COMBINATION THERAPY USING TESTOSTERONE REPLACEMENT THERAPY, PHOSPHODIESTERASE 5 INHIBITORS AND KAMPO HERBAL MEDICINE FOR EUGONADAL PATIENTS WITH LATE-ONSET HYPOGONADISM SYNDROME
    Takeuchi, H.
    Okubo, H.
    Komatsu, N.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S178 - S178
12345